Ye Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 8
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 4
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 6
- Co-authors
- Angang Yang (5 shared papers)Rui Zhang (5 shared papers)Yidi Wang (2 shared papers)Xiang Zhang (2 shared papers)Chunsheng Kang (6 shared papers)Xiaofang Zhang (2 shared papers)Yanping Yu (2 shared papers)Yanli Tan (5 shared papers)
- Journals
- Theranostics (4 papers)Cell Death and Differentiation (3 papers)Nature Communications (2 papers)Biochemical and Biophysical Research Communications (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Ye Wu
35 papers receiving 1.3k citations
Ye Wu's Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 406
- Molecular Biology 864
- Pulmonary and Respiratory Medicine 243
- Immunology 120
- Oncology 128
Countries citing papers authored by Ye Wu
This map shows the geographic impact of Ye Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Wu more than expected).
Fields of papers citing papers by Ye Wu
This network shows the impact of papers produced by Ye Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Wu. The network helps show where Ye Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming Hit paper breakdown → | 2021 | 320 |
| 2 | 2021 | 168 | |
| 3 | 2019 | 147 | |
| 4 | 2019 | 117 | |
| 5 | 2020 | 73 | |
| 6 | 2022 | 71 | |
| 7 | 2022 | 46 | |
| 8 | 2021 | 41 | |
| 9 | 2011 | 38 | |
| 10 | 2022 | 30 | |
| 11 | 2022 | 22 | |
| 12 | 2019 | 21 | |
| 13 | 2016 | 18 | |
| 14 | 2021 | 18 | |
| 15 | 2018 | 16 | |
| 16 | 2019 | 16 | |
| 17 | 2025 | 14 | |
| 18 | 2025 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2018 | 13 |
About Ye Wu
Ye Wu is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Genetics and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (4 papers), Circular RNAs in diseases (4 papers), Extracellular vesicles in disease (4 papers), Spinal Cord Injury Research (3 papers) and Barrier Structure and Function Studies (2 papers). The work is most often cited by research in Cancer Research (406 citations), Molecular Biology (864 citations), Pulmonary and Respiratory Medicine (243 citations), Immunology (120 citations) and Oncology (128 citations). Ye Wu has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Angang Yang, Rui Zhang, Yidi Wang, Xiang Zhang, Chunsheng Kang, Xiaofang Zhang, Yanping Yu, Yanli Tan, Qixue Wang and Junhu Zhou. Their work appears in journals such as Theranostics, Cell Death and Differentiation, Nature Communications, Biochemical and Biophysical Research Communications and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.